GAMMA Investing’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.3K Buy
5,782
+2,376
+70% +$28.4K ﹤0.01% 1991
2026
Q1
$20.4K Sell
3,406
-376
-10% -$2.83K ﹤0.01% 2704
2025
Q4
$27.1K Sell
3,782
-3,128
-45% -$24.7K ﹤0.01% 2444
2025
Q3
$73.8K Buy
6,910
+1,265
+22% +$12.4K ﹤0.01% 1725
2025
Q2
$54.6K Buy
5,645
+1,034
+22% +$10.7K ﹤0.01% 1876
2025
Q1
$68.7K Buy
4,611
+3,004
+187% +$46.2K 0.01% 1555
2024
Q4
$24K Sell
1,607
-4,755
-75% -$77.5K ﹤0.01% 2171
2024
Q3
$122K Buy
6,362
+2,326
+58% +$48.2K 0.01% 873
2024
Q2
$83.5K Buy
4,036
+649
+19% +$12.9K 0.01% 874
2024
Q1
$63.7K Buy
3,387
+772
+30% +$13.2K 0.01% 876
2023
Q4
$43.5K Buy
+2,615
New +$35.6K 0.01% 976

Other funds holding OGN

GAMMA Investing's OGN Position: Q2 2026 in Review

GAMMA Investing increased its Organon & Co (OGN) stake by 70% in Q2 2026, buying an estimated $28.4K and bringing the position to 5,782 shares worth $78.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1991.

GAMMA Investing first reported a position in OGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $122K in Q3 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • GAMMA Investing held 5,782 shares of Organon & Co worth $78.3K as of Q2 2026.
  • GAMMA Investing bought 2,376 Organon & Co shares in Q2 2026, an estimated $28.4K.
  • Organon & Co made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1991 holding.
  • GAMMA Investing first reported a position in Organon & Co in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Organon & Co position peaked at $122K in Q3 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.